Intervention Review

Dopamine agonists for the treatment of restless legs syndrome

  1. Hanna Scholz1,
  2. Claudia Trenkwalder2,
  3. Ralf Kohnen3,
  4. Levente Kriston4,
  5. Dieter Riemann5,
  6. Magdolna Hornyak1,*

Editorial Group: Cochrane Movement Disorders Group

Published Online: 15 MAR 2011

Assessed as up-to-date: 18 JAN 2011

DOI: 10.1002/14651858.CD006009.pub2

How to Cite

Scholz H, Trenkwalder C, Kohnen R, Kriston L, Riemann D, Hornyak M. Dopamine agonists for the treatment of restless legs syndrome. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD006009. DOI: 10.1002/14651858.CD006009.pub2.

Author Information

  1. 1

    University Medical Center, Freiburg, Interdisciplinary Pain Canter, Freiburg, Germany

  2. 2

    Paracelsus - Elena Hospital, Centre of Parkinson and Movement Disorders, Kassel, Germany

  3. 3

    RPS Research Germany GmbH, Nuremberg and University Erlangen-Nuremberg, Nürnberg, Germany

  4. 4

    University Medical Center, Hamburg - Eppendorf, Department of Medical Psychology, Hamburg, Germany

  5. 5

    University Medical Center, Freiburg, Department of Psychiatry and Psychotherapy, Freiburg, Germany

*Magdolna Hornyak, Interdisciplinary Pain Canter, University Medical Center, Freiburg, Breisacher Strasse, 64, Freiburg, 79106, Germany.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 15 MAR 2011


  1. Current Version

    Dopamine agonists for the treatment of restless legs syndrome

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Version of Record online: 15 MAR 2011 | DOI: 10.1002/14651858.CD006009.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Dopamine agonists for restless legs syndrome

    Magdolna Hornyak, Michael M Berner, Levente Kriston and Dieter Riemann

    Version of Record online: 19 APR 2006 | DOI: 10.1002/14651858.CD006009